SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 245 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $12,087,000 | -71.9% | 69,956 | -81.3% | 0.01% | -74.1% |
| Q4 2014 | $43,066,000 | +34.0% | 374,702 | +82.2% | 0.03% | +35.0% |
| Q3 2014 | $32,136,000 | +25.6% | 205,701 | -0.9% | 0.02% | +17.6% |
| Q2 2014 | $25,592,000 | +23.3% | 207,499 | +3.4% | 0.02% | +13.3% |
| Q1 2014 | $20,756,000 | -9.7% | 200,735 | -21.5% | 0.02% | -11.8% |
| Q4 2013 | $22,984,000 | +122.3% | 255,579 | +65.3% | 0.02% | +112.5% |
| Q3 2013 | $10,340,000 | – | 154,644 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |